<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890057</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0280</org_study_id>
    <nct_id>NCT01890057</nct_id>
  </id_info>
  <brief_title>The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To find out the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from
      profound rocuronium-induced neuromuscular block in young and elderly adult patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A previous study reported that elderly patients required a longer time to recover from
      rocuronium induced neuromuscular block compared to younger patients. Therefore, the aim of
      this study is to find out the dose of sugammadex for rapid recovery from profound
      neuromuscular block in young and elderly adult patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block</measure>
    <time_frame>2 hour</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Anesthesia Recovery Period, Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Young adults</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To find out the the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block : Dixon's up-and-down method</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Elderly adults</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To find out the the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound neuromuscular block : Dixon's up-and-down method</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sugammadex</intervention_name>
    <description>The dose of sugammadex</description>
    <arm_group_label>Young adults</arm_group_label>
    <arm_group_label>Elderly adults</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20-40 years or â‰¥70 years ASA class I-II patients who received surgery less than 2
             hours.

        Exclusion Criteria:

          -  anticipated difficult intubation

          -  neuromuscular, hepatic or renal disorders

          -  drug allergy

          -  body mass index &gt;30 kg/m2 or body mass index &lt;18 kg/m2

          -  emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2013</study_first_submitted>
  <study_first_submitted_qc>June 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <last_update_submitted>February 2, 2014</last_update_submitted>
  <last_update_submitted_qc>February 2, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>So Yeon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

